» Articles » PMID: 27788692

Deferiprone Reduces Hemosiderin Deposition in Superficial Siderosis

Overview
Specialty Neurology
Date 2016 Oct 30
PMID 27788692
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Treatment Response of Deferiprone in Infratentorial Superficial Siderosis: a Systematic Review.

Martin A, Shanmugarajah P, Hoggard N, Hadjivassiliou M Cerebellum. 2021; 20(3):454-461.

PMID: 33409768 PMC: 8213658. DOI: 10.1007/s12311-020-01222-7.


Recent Advances in the Treatment of Cerebellar Disorders.

Mitoma H, Manto M, Gandini J Brain Sci. 2019; 10(1).

PMID: 31878024 PMC: 7017280. DOI: 10.3390/brainsci10010011.


Ataxia.

Kuo S Continuum (Minneap Minn). 2019; 25(4):1036-1054.

PMID: 31356292 PMC: 7339377. DOI: 10.1212/CON.0000000000000753.


Focused Neuro-Otological Review of Superficial Siderosis of the Central Nervous System.

Yoo A, Jou J, Klopfenstein J, Kattah J Front Neurol. 2018; 9:358.

PMID: 29892257 PMC: 5985612. DOI: 10.3389/fneur.2018.00358.


Two-year observational study of deferiprone in superficial siderosis.

Kessler R, Li X, Schwartz K, Huang H, Mealy M, Levy M CNS Neurosci Ther. 2017; 24(3):187-192.

PMID: 29285884 PMC: 6489821. DOI: 10.1111/cns.12792.

References
1.
Levy M, Llinas R . Update on a patient with superficial siderosis on deferiprone. AJNR Am J Neuroradiol. 2012; 33(6):E99-100. PMC: 8013263. DOI: 10.3174/ajnr.A3186. View

2.
Schmitz-Hubsch T, Tezenas Du Montcel S, Baliko L, Berciano J, Boesch S, Depondt C . Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006; 66(11):1717-20. DOI: 10.1212/01.wnl.0000219042.60538.92. View

3.
Cossu G, Abbruzzese G, Matta G, Murgia D, Melis M, Ricchi V . Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up. Parkinsonism Relat Disord. 2014; 20(6):651-4. DOI: 10.1016/j.parkreldis.2014.03.002. View

4.
Levy M, Llinas R . Pilot safety trial of deferiprone in 10 subjects with superficial siderosis. Stroke. 2011; 43(1):120-4. DOI: 10.1161/STROKEAHA.111.628032. View

5.
Pandolfo M, Arpa J, Delatycki M, Sang K, Mariotti C, Munnich A . Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. Ann Neurol. 2014; 76(4):509-21. DOI: 10.1002/ana.24248. View